Basheer M, Saad E and Assy N: Methylprednisolone Decrease In - Hospital Mortality in Patients with COVID-19 Pneumonia (Japanese J Gstro Hepato.)

Acute respiratory distress can occur in patients with COVID-19 disease due to viral replication of SARS-COV-2 and an uncontrolled immune inflammatory reaction. We compared the  efficacy of intravenous methylprednisolone and intravenous dexamethasone on mortality rate in severe COVID-19 patients with pneumonia and hypoxemia using the new 4C mortality score on admission and on discharge